Back to today’s briefing

Story perspectives

Pharma Groups Challenge Biden's Drug Price Negotiation Legally

1/14/2025

41 8

Summary

Story summary

In a bold move, the Pharmaceutical Research and Manufacturers of America, joined by the National Infusion Center Association and the Global Colon Cancer Association, is taking a stand against the Biden administration's Medicare Drug Price Negotiation Program. They claim the program violates the Constitution and are pushing for a quick decision from the US District Court in Texas.

1 of 1

Story summary

In a bold move, the Pharmaceutical Research and Manufacturers of America, joined by the National Infusion Center Association and the Global Colon Cancer Association, is taking a stand against the Biden administration's Medicare Drug Price Negotiation Program. They claim the program violates the Constitution and are pushing for a quick decision from the US District Court in Texas.